title: Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer.
abstract: Breast cancer represents one of the most frequently diagnosed cancers and predominant causes of death in women worldwide. The value of preventive therapy to limit the devastating impact of breast cancer is well established. Various plant triterpenoids and their synthetic analogs have shown significant promise as potent chemopreventive agents in breast cancer. The current study was initiated to investigate mechanism-based chemopreventive potential of a novel synthetic oleanane triterpenoid (methyl-25-hydroxy-3-oxoolean-12-en-28-oate, AMR-Me) against 7,12-dimethylbenz(a)anthracene (DMBA)-initiated rat mammary carcinogenesis, an experimental rodent tumor model that closely resembles human mammary cancer. Rats were orally administered with AMR-Me (0.8, 1.2 and 1.6 mg/kg) three times per week for 18 weeks. Following two weeks of AMR-Me treatment, mammary carcinogenesis was initiated by oral administration of DMBA (50 mg/kg body weight). At the end of the study (16 weeks following DMBA exposure), AMR-Me exhibited a striking inhibition of DMBA-induced mammary tumor incidence, total tumor burden, average tumor weight and reversed histopathological alterations without toxicity. AMR-Me dose-dependently suppressed abnormal cell proliferation, induced apoptosis, up-regulated pro-apoptotic protein Bax and down-regulated antiapoptotic protein Bcl-2 in mammary tumors. AMR-Me upregulated the transcriptional levels of Bax, Bad, caspase-3, caspase-7 and poly(ADP-ribose) polymerase and down-regulated Bcl-2. These results clearly demonstrate for the first time that novel triterpenoid AMR-Me exerts chemopreventive efficacy in the classical DMBA model of breast cancer by suppressing abnormal cell proliferation and inducing apoptosis mediated through mitochondrial pro-apoptotic mechanisms. AMR-Me could be developed as a chemopreventive drug to reduce the risk of human breast cancer that remains a devastating disease.
authors: Department of Pharmaceutical Sciences, School of Pharmacy, American University of Health Sciences, Signal Hill, CA 90755, USA. abishayee@auhs.edu
authors: Anupam
authors: A
authors: Bishayee
authors: Animesh
authors: A
authors: Mandal
authors: Roslin J
authors: RJ
authors: Thoppil
authors: Altaf S
authors: AS
authors: Darvesh
authors: Deepak
authors: D
authors: Bhatia
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D009828:Oleanolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D016588:Anticarcinogenic Agents; C530744:methyl 25-hydroxy-3-oxoolean-12-en-28-oate; D015127:9,10-Dimethyl-1,2-benzanthracene; D009828:Oleanolic Acid
keywords: DMBA; apoptosis; breast cancer; cell proliferation; chemoprevention; oleanane triterpenoid
references: Braz J Med Biol Res. 1989;22(4):447-55
references: 2511986
references: Anticancer Agents Med Chem. 2012 Dec;12(10):1185-202
references: 22583403
references: Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5488-96
references: 17875779
references: Front Biosci (Landmark Ed). 2011 Jan 01;16:980-96
references: 21196213
references: Arch Pathol Lab Med. 2002 Aug;126(8):915-27
references: 12171489
references: Clin Cancer Res. 2006 Jun 15;12(12):3661-97
references: 16778094
references: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references: 21296855
references: Carcinogenesis. 2000 Mar;21(3):427-33
references: 10688862
references: Apoptosis. 2002 Aug;7(4):313-9
references: 12101390
references: J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):67-76
references: 12160087
references: Endocr Rev. 1999 Jun;20(3):253-78
references: 10368771
references: Lancet Oncol. 2011 May;12(5):496-503
references: 21441069
references: Nature. 1990 Nov 22;348(6299):334-6
references: 2250705
references: Prev Med. 1993 Sep;22(5):750-66
references: 8234215
references: Cancer Prev Res (Phila). 2012 Jan;5(1):89-97
references: 21933912
references: Nat Rev Cancer. 2007 Jan;7(1):46-53
references: 17186017
references: Mol Carcinog. 2008 Jun;47(6):415-23
references: 18058803
references: Cancer Lett. 2005 Sep 28;227(2):115-24
references: 16112414
references: Cancer Res. 1995 Apr 1;55(7):1401-6
references: 7882342
references: Front Biosci (Elite Ed). 2012 Jan 01;4:546-67
references: 22201894
references: Cancer Res. 2003 Sep 15;63(18):5926-39
references: 14522919
references: Breast Cancer Res Treat. 2003 Aug;80(3):321-30
references: 14503804
references: Cancer Treat Rev. 2012 Aug;38(5):329-39
references: 21856081
references: Chem Biol Interact. 2009 May 15;179(2-3):131-44
references: 19073162
references: Carcinogenesis. 2010 May;31(5):886-93
references: 20110282
references: Int J Cancer. 2003 Jul 20;105(6):784-9
references: 12767063
references: Breast Cancer Res Treat. 2000 Sep;63(2):133-45
references: 11097089
references: J Clin Pathol. 1992 May;45(5):416-9
references: 1350788
references: Mol Cancer Ther. 2006 Feb;5(2):317-28
references: 16505105
references: J Cell Sci. 2009 Feb 15;122(Pt 4):437-41
references: 19193868
references: Cancer Res. 2007 May 1;67(9):4210-8
references: 17483332
references: Ann N Y Acad Sci. 2008 Sep;1138:121-31
references: 18837892
references: Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):249-55
references: 17267389
references: Clin Cancer Res. 2003 Jul;9(7):2798-806
references: 12855660
references: Cancer Prev Res (Phila). 2009 Aug;2(8):712-9
references: 19654106
references: Phytother Res. 2002 Mar;16 Suppl 1:S84-6
references: 11933149
references: Breast Cancer Res Treat. 2007 Jan;101(1):27-36
references: 17028990
references: Mol Nutr Food Res. 2012 Jan;56(1):14-29
references: 22125182
references: Recent Results Cancer Res. 2011;188:147-62
references: 21253797
references: Lab Invest. 1990 Mar;62(3):244-78
references: 2107367
references: Int J Cancer. 2006 Nov 15;119(10):2443-54
references: 16894569
references: Biochem Pharmacol. 1990 Jun 15;39(12):1837-46
references: 2191651
references: Cell Metab. 2009 May;9(5):401-3
references: 19416708
references: Breast Cancer Res Treat. 2009 May;115(2):223-39
references: 18636327
references: Clin Cancer Res. 2008 Jul 15;14(14):4556-63
references: 18628471
references: Toxicol Ind Health. 2012 Sep;28(8):746-57
references: 22089659
references: Cancer Lett. 2009 Jun 18;278(2):156-163
references: 19201082